Diabetes AtlasGlobal estimates of the prevalence of diabetes for 2010 and 2030
Introduction
Diabetes mellitus is one of the most common chronic diseases in nearly all countries, and continues to increase in numbers and significance, as changing lifestyles lead to reduced physical activity, and increased obesity. Estimates of the current and future burden of diabetes are important in order to allocate community and health resources, and to emphasise the role of lifestyle, and encourage measures to counteract trends for increasing prevalence.
There have been several previous estimates of the number of persons with diabetes [1], [2], [3], [4]. The World Health Organization (WHO) published estimates for the years 2000 and 2030, using data from 40 countries but extrapolated to the 191 WHO member states [4]. Other estimates have been produced by the International Diabetes Federation (IDF) [5], [6]. The estimates produced here update the previous IDF estimates, and include all 216 countries of the United Nations.
Section snippets
Study selection
The Medline database was searched for publications between January 1989 and March 2009, using the following search term “Diabetes Mellitus/epidemiology” MeSH AND “Prevalence” MeSH. Studies were identified that reported on the prevalence of diabetes for at least three adult age-groups from a population-based sample. A number of other avenues were explored in the search for relevant data. Relevant citations from each article were obtained, and diabetes researchers in each major IDF geographical
Results
There were 133 studies identified from 91 countries. The data sources and the results for the 80 most populous countries (those with 2010 adult population of greater than 6.307 million, with a combined 2010 population of 95% of the world adult population) are shown in Table 1, Table 2. There were 47 of the 80 countries that had their own data (85 separate studies). Details of prevalence and case numbers for all 216 countries can be found in the online Appendix.
The highest regional prevalence (
Discussion
These estimates suggest that in 2010 there will be 285 million people worldwide with diabetes, with considerable disparity between populations and regions. The pattern of diabetes varies considerably according to countries’ economic status. For developed countries, the majority with diabetes are aged over 60 years, whereas for developing countries most people with diabetes are of working age, between 40 and 60 years. This difference is likely to still be present in 2030, although less marked,
Conflict of interest
There are no conflicts of interest.
Acknowledgements
The authors would like to thank the members of the IDF Diabetes Atlas Committee (JC Mbanya, D Gan, B Allgot, K Bakker, J Brown, A Ramachandran, M Silink, L Siminerio, G Soltesz, R Williams) for their advice in compiling these estimates. Funding was provided by the IDF.
References (104)
- et al.
The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS)
Diabetes Res. Clin. Pract.
(2004) - et al.
Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population
Diabetes Res. Clin. Pract.
(1999) - et al.
Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living
Trans. R. Soc. Trop. Med. Hyg.
(2000) - et al.
Diabetes in Ghana: a community based prevalence study in Greater Accra
Diabetes Res. Clin. Pract.
(2002) - et al.
Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study
Diabetes Res. Clin. Pract.
(2007) - et al.
Diabetes and associated disorders in Cambodia: two epidemiological surveys
Lancet
(2005) - et al.
Urban rural differences in prevalence of self-reported diabetes in India—the WHO-ICMR Indian NCD risk factor surveillance
Diabetes Res. Clin. Pract.
(2008) - et al.
Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study
J. Diabetes Complications
(2000) - et al.
Prevalence and correlates of diabetes mellitus and impaired glucose tolerance among adults in Luzon, Philippines
Diabetes Res. Clin. Pract.
(2004) - et al.
Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study
Lancet
(2007)
Prevalence of diabetes mellitus and metabolic syndrome in Slovakia
Diabetes Res. Clin. Pract.
Prevalence and treatment of diabetes in France: trends between 2000 and 2005
Diabetes Metab.
Prevalence of diabetes mellitus in Croatia
Diabetes Res. Clin. Pract.
Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study
Diabetes Res. Clin. Pract.
Prevalence of diabetes mellitus in the province of Girona, Spain: the REGICOR study
Rev. Espanola Cardiol.
Prevalence of diabetes in Murcia (Spain): a Mediterranean area characterised by obesity
Diabetes Res. Clin. Pract.
Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina
Diabetes Metab.
Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in Baluchistan province
Diabetes Res. Clin. Pract.
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Diabetes Res. Clin. Pract.
Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province
Diabetes Res. Clin. Pract.
Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
Diabetes Care
Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections
Diabetes Care
The rising global burden of diabetes and its complications: estimates and projections to the year 2010
Diabet. Med.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
Diabetes Atlas
Diabetes Atlas
Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
Diabetes Care
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey
Diabetologia
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA)
Diabetologia
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Diabetes Care
Prevalence of diabetes and its risk factors in China
Diabetes Care
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002
Diabetes Care
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study
Diabetes Care
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
Diabetologia
Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967–1991—the Reykjavik Study
Diabet. Med.
Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP)
Diabetes Care
Prevalence of diabetes and impaired glucose tolerance in rural Tanzania
Lancet
The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks
SAMJ
The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa
Diabetes Care
Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa
SAMJ
Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors
Diabetes Care
Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh
Diabet. Med.
Diabetes and impaired fasting glycemia in a rural population of Bangladesh
Diabetes Care
Cited by (5425)
Dichloroacetate ameliorates apoptosis, EMT and oxidative stress in diabetic cataract via inhibiting the IDO1-dependent p38 MAPK pathway
2024, Molecular and Cellular EndocrinologyAn interpretable dual attention network for diabetic retinopathy grading: IDANet
2024, Artificial Intelligence in Medicine